Factor ixa for the treatment of bleeding disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/36 (2006.01) A61P 7/04 (2006.01)

Patent

CA 2557061

The invention provides a method of treating bleeding disorders in a subject by administration of a preparation enriched for Factor IXa. The Factor IXa can be produced by proteolytically activating recombinantly-produced Factor IX. The invention also provides an improved method for producing Factor IXa from a plasma fraction, which method results in a Factor IXa product containing little or no prekallikrein activity, thus reducing the incidence of undesired side effects in a subject.

L'invention concerne une méthode de traitement de troubles de saignement chez un sujet, par l'administration d'une préparation enrichie en facteur IXa. Le facteur IXa peut être produit par l'activation protéolytique du facteur IX produit par recombinaison. L'invention porte également sur une méthode améliorée de production du facteur IXa à partir d'une fraction de plasma, qui permet d'obtenir un produit du facteur IXa ayant une activité de prékallikréine faible ou inexistante, et de réduire ainsi l'incidence des effets secondaires indésirables chez un sujet.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Factor ixa for the treatment of bleeding disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Factor ixa for the treatment of bleeding disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor ixa for the treatment of bleeding disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1894078

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.